Capricor Therapeutics Inc
NASDAQ:CAPR

Watchlist Manager
Capricor Therapeutics Inc Logo
Capricor Therapeutics Inc
NASDAQ:CAPR
Watchlist
Price: 18.71 USD 1.19% Market Closed
Market Cap: 608.8m USD
Have any thoughts about
Capricor Therapeutics Inc?
Write Note

Capricor Therapeutics Inc
PP&E Gross

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Capricor Therapeutics Inc
PP&E Gross Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive PP&E Gross Analysis
Latest Figures & CAGR of Competitors

Company PP&E Gross CAGR 3Y CAGR 5Y CAGR 10Y
Capricor Therapeutics Inc
NASDAQ:CAPR
PP&E Gross
$7.3m
CAGR 3-Years
87%
CAGR 5-Years
70%
CAGR 10-Years
43%
Abbvie Inc
NYSE:ABBV
PP&E Gross
$5B
CAGR 3-Years
-1%
CAGR 5-Years
9%
CAGR 10-Years
8%
Gilead Sciences Inc
NASDAQ:GILD
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
PP&E Gross
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Capricor Therapeutics Inc's PP&E Gross?
PP&E Gross
7.3m USD

Based on the financial report for Jun 30, 2024, Capricor Therapeutics Inc's PP&E Gross amounts to 7.3m USD.

What is Capricor Therapeutics Inc's PP&E Gross growth rate?
PP&E Gross CAGR 10Y
43%

Over the last year, the PP&E Gross growth was 7%. The average annual PP&E Gross growth rates for Capricor Therapeutics Inc have been 87% over the past three years , 70% over the past five years , and 43% over the past ten years .

Back to Top